StemCell Institute Inc. (TYO:7096)
Japan · Delayed Price · Currency is JPY 820.00
-22.00 (-2.61%)
At close: Mar 27, 2026
StemCell Institute Market Cap
StemCell Institute has a market cap or net worth of 8.4 billion as of March 27, 2026. Its market cap has decreased by -30.15% in one year.
Market Cap
8.40B
Enterprise Value
6.22B
Revenue
2.78B
Ranking
n/a
PE Ratio
43.30
Stock Price
820.00
Market Cap Chart
Since June 25, 2021, StemCell Institute's market cap has decreased from 21.16B to 8.40B, a decrease of -60.29%. That is a compound annual growth rate of -17.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 8.40B | 3.40% |
| Dec 30, 2025 | 8.13B | -38.48% |
| Dec 30, 2024 | 13.21B | -39.88% |
| Dec 29, 2023 | 21.97B | -17.47% |
| Dec 30, 2022 | 26.62B | 9.16% |
| Dec 30, 2021 | 24.39B | 15.25% |
| Jun 25, 2021 | 21.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellSeed | 11.09B |
| BrightPath Biotherapeutics | 9.75B |
| K Pharma,Inc. | 9.18B |
| MEDINET | 8.00B |
| ADR120S | 7.94B |
| OncoTherapy Science | 7.91B |
| CellSource | 7.60B |
| Chiome Bioscience | 7.22B |